CVE-2011-4938

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in Ariadne 2.7.6 allow remote attackers to inject arbitrary web script or HTML via the PATH_INFO parameter to (1) index.php and (2) loader.php.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.78% Top 30%
Third-Party Advisory openwall.com Third-Party Advisory openwall.com Third-Party Advisory seclists.org
Affected: Ariadne Ariadne
Published at:
Updated at:

References

Link Tags
http://www.rul3z.de/advisories/SSCHADV2011-038.txt not applicable
http://www.openwall.com/lists/oss-security/2012/03/09/4 third party advisory mailing list
http://www.openwall.com/lists/oss-security/2012/03/10/6 third party advisory mailing list
http://bugs.ariadne-cms.org/view.php?id=277 broken link
https://seclists.org/bugtraq/2011/Dec/7 mailing list exploit third party advisory

Frequently Asked Questions

What is the severity of CVE-2011-4938?
CVE-2011-4938 has been scored as a medium severity vulnerability.
How to fix CVE-2011-4938?
To fix CVE-2011-4938, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-4938 being actively exploited in the wild?
It is possible that CVE-2011-4938 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2011-4938?
CVE-2011-4938 affects Ariadne Ariadne.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.